Lower-Dose CRRT May Cut AKI Mortality
SAN DIEGO—Lower-dose continuous renal replacement therapy (CRRT) for critically ill patients with acute kidney injury (AKI) may boost their likelihood of survival, according to a new study.
Renal Replacement Therapy
CKD Progresses More Slowly in Women
Data show that men are 30% more likely than women to start renal replacement therapy
Degree of Fluid Overload Influences AKI Outcomes
Fluid overload greater than 20% at the start of continuous renal replacement therapy (CRRT) increases the risk of death among pediatric ICU patients with acute kidney injury, researchers concluded.
CRRT May Speed Renal Recovery in AKI Patients
HOUSTON—Continuous renal replacement therapy (CRRT) may shorten renal recovery time in patients who experience acute kidney injury (AKI) following open heart surgery (OHS), according to researchers at Pusan National University School of Medicine in Pusan, Korea.
Outcomes Not Improved With Intensive RRT
Intensive renal replacement therapy (RRT) in critically ill patients with acute kidney injury does not improve outcomes, according to researchers.
Dialysis Techniques for ARF May Yield Similar Outcomes
Intermittent hemodialysis and continuous renal replacement therapy (CRRT) appear to lead to similar clinical outcomes for patients with acute renal failure (ARF), according to researchers who reviewed 30 randomized controlled trials and eight prospective cohort studies.
Pre-ESRD Care, Insurance Type Linked
SAN FRANCISCO—Medicaid patients are less likely to have seen a nephrologist or kidney dietitian prior to starting renal replacement therapy (RRT) compared with patients covered by Medicare or employer group health insurance, data show.
Gadolinium Peril Confirmed
Scottish researchers have confirmed an association between gadolinium-based contrast agent use and development of nephrogenic systemic fibrosis (NSF) in patients with renal failure undergoing renal replacement therapy (RRT), according to a report in Radiology (2007; published online ahead of print).
- Loading...
Loading...
Loading... 
Loading...